Montreal Classification for Inflammatory Bowel Disease (IBD)

Montreal IBD Classification
Disease Type
Age at Diagnosis
Location
Behavior
Perianal Disease Modifier
Extent (UC)
Classification: Classified
Montreal Classification
Crohn's Disease: A1 (<16 years), L1 (ileal), B1 (non-stricturing, non-penetrating)
Classifies severity of Crohn's disease and ulcerative colitis.

Why Use

Provides a structured approach to describe the severity and characteristics of IBD. Facilitates communication among healthcare providers by using a standardized terminology. Aids in predicting disease progression and determining the need for aggressive management.

When to Use

Use during the initial diagnostic evaluation and follow-up of Crohn disease or ulcerative colitis to categorize patients into specific phenotypes and guide treatment planning. May be used in research or clinical trials to ensure standardized classification of patient populations.

Formula

Criteria for Crohn’s disease: Criteria Age at diagnosis, years (A) A1 ≤16 A2 17-40 A3 >40 Location (L) L1 Terminal ileum L2 Colon L3 Ileocolon L4* Upper GI Behavior (B) B1 Nonstricturing, nonpenetrating B2 Stricturing B3 Penetrating p** Perianal *L4 is a modifier that can be added to L1, L2, or L3 when concomitant upper gastrointestinal disease is present. **p is a modifier that can be added to B1, B2, or B3 when concomitant perianal disease is present. Criteria for ulcerative colitis: Criteria Extent (E) E1 Ulcerative proctitis: involvement limited to the rectum (i.e., proximal extent of inflammation is distal to the rectosigmoid junction) E2 Left-sided UC (also known as distal UC): involvement limited to the portion of the colorectum distal to the splenic flexure E3 Extensive UC (also known as pancolitis): involvement extends proximal to the splenic flexure Severity (S) S0 UC in clinical remission: no symptoms of UC S1 Mild UC: ≤4 bloody stools daily, lack of fever, pulse <90 bpm, hemoglobin ≥10.5 g/dL (105 g/L), erythrocyte sedimentation rate <30 mm/hr S2 Moderate UC: >4-5 stools daily but with minimal signs of systemic toxicity S3 Severe UC: ≥6 bloody stools daily, pulse ≥90 bpm, temperature ≥99.5°F (37.5°C), hemoglobin <10.5 g/dL (105 g/L), and erythrocyte sedimentation rate ≥30 mm/hr

Pearls / Pitfalls

The Montreal Classification is descriptive but does not incorporate newer insights into the molecular or immunologic underpinnings of inflammatory bowel disease (IBD). Reclassification may be needed as the disease evolves over time.

Advice

Use the classification results to tailor treatment options, such as immunomodulators, biologics, or surgery, based on disease severity and phenotype. Incorporate classification results into multidisciplinary discussions, including gastroenterologists and surgeons, to optimize patient care. Monitor disease progression and reassess the classification periodically, particularly in cases of changing clinical presentation or treatment failure. Do not use this tool as the sole determinant of management decisions; clinical context, patient history, specialist consultation, and other diagnostic tools are essential. For more detailed management recommendations, please refer to regional guidelines, such as those from the American Gastroenterological Association , American College of Gastroenterology , and American Society of Colon and Rectal Surgeons .

Similar Posts